Blunted sFasL signalling exacerbates TNF‐driven neutrophil necroptosis in critically ill COVID‐19 patients
Abstract Objectives Critically ill coronavirus disease 2019 (COVID‐19) patients are characterised by a severely dysregulated cytokine profile and elevated neutrophil counts, impacting disease severity. However, it remains unclear how neutrophils contribute to pathophysiology during COVID‐19. Here, w...
Main Authors: | Tiziano A Schweizer, Srikanth Mairpady Shambat, Clement Vulin, Sylvia Hoeller, Claudio Acevedo, Markus Huemer, Alejandro Gomez‐Mejia, Chun‐Chi Chang, Jeruscha Baum, Sanne Hertegonne, Eva Hitz, Thomas C Scheier, Daniel A Hofmaenner, Philipp K Buehler, Holger Moch, Reto A Schuepbach, Silvio D Brugger, Annelies S Zinkernagel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Clinical & Translational Immunology |
Subjects: | |
Online Access: | https://doi.org/10.1002/cti2.1357 |
Similar Items
-
Plasma Levels of sFas-sFasL and <i>FASL</i> Gene Expression Are Associated with Tuberculosis
by: Iury de Paula Souza, et al.
Published: (2022-12-01) -
Serum levels of sFas and sFasL in subjects with type 2 diabetes — the impact of arterial hypertension
by: Stoynev Nikolay, et al.
Published: (2014-10-01) -
sFasL—The Key to a Riddle: Immune Responses in Aging Lung and Disease
by: Shulamit B. Wallach-Dayan, et al.
Published: (2021-02-01) -
Diagnostic significance of serum concentrations of soluble Fas ligand (sFasL) in children with autoimmune thyroid disease
by: Hanna Mikos, et al.
Published: (2017-04-01) -
Evaluation of diabetic polyneuropathy in Type 2 diabetes mellitus by nerve conduction study and association of severity of neuropathy with serum sFasL level
by: Avijit Mondal, et al.
Published: (2012-01-01)